Abstract

Inherited retinal degenerations (IRD) affecting either photoreceptors or pigment epithelial cells cause progressive visual loss and severe disability, up to complete blindness. Retinal organoids (ROs) technologies opened up the development of human inducible pluripotent stem cells (hiPSC) for disease modeling and replacement therapies. However, hiPSC-derived ROs applications to IRD presently display limited maturation and functionality, with most photoreceptors lacking well-developed outer segments (OS) and light responsiveness comparable to their adult retinal counterparts. In this review, we address for the first time the microenvironment where OS mature, i.e., the subretinal space (SRS), and discuss SRS role in photoreceptors metabolic reprogramming required for OS generation. We also address bioengineering issues to improve culture systems proficiency to promote OS maturation in hiPSC-derived ROs. This issue is crucial, as satisfying the demanding metabolic needs of photoreceptors may unleash hiPSC-derived ROs full potential for disease modeling, drug development, and replacement therapies.

Highlights

  • The notion of immature photoreceptor precursors in human inducible pluripotent stem cells (hiPSC)-derived Retinal organoids (ROs) is consistent with the analysis of voltage- and cGMP-gated currents carried out at different developmental time of ROs generated with the same mixed 2D–3D protocol used to generate ROs with functional PRC [132]

  • Demonstrate the possibility of generating and isolating properly developed donor cells for transplantation. These impressive achievements represent an undeniable success that paves the way toward developing a cure for Inherited retinal degenerations (IRD) by replacing missing cells with iPSC-derived cells

  • In vitro modeling of IRD caused by defective genes coding for phototransduction components requires the well-developed outer segments (OS) to investigate the pathogenetic mechanisms associated with the misfolding of highly expressed proteins, such as rhodopsin, or the metabolic overload caused by variants affecting cGMP turnover

Read more

Summary

Introduction

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Cyan arrows: downward transfer of rod-borne signals via primary and secondary rod depolarizing rod BC (blue). Horizontal cyan arrows indicate the transfer of rod-borne signals to pathways. Primary rod pathway: downward pointing cyan arrows indicate rod responses transfer cone BC by AII AC (orange), via a chemical synapsis with HCB and an electrical synapsis (red circle to depolarizing rod BC (blue). Horizontal cyan arrows indicate the transfer of rod-borne signals to containing a resistor symbol) with depolarizing CB. Secondary rod pathway: horizontal cyan arrows cone BC by AII AC (orange), via a chemical synapsis with HCB and an electrical synapsis Secondary rod pathway: horizontal cyan arrows indicate the transfer of rod-borne signals to cones via electrical synapses.

G Protein Subunit A Transducin
Disease Modeling by hiPSC-Derived ROs and Drug Development for Retinal IRD
IRD Treatments
The Path from Retinal Development to ROs
Derivation of 3D ROs from iPSC
Morphological and Transcriptomic Limitations of iPSC-Derived ROs
Functional Limitations of hiPSC-Derived ROs
The SRS Microenvironment
SRS Structures
SRS Biochemical and Functional Features
Oxygen Levels in the SRS and the Outer Retina
Bioengineering the SRS Microenvironment
Limitations of Conventional Static Culture Systems
Dynamic Culture Systems
Findings
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call